Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral testosterone for sarcopenia in men with prostate cancer receiving ADT
ACTRN12616001166460Phase 2Recruiting
- Sponsor
- Metro South Health
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Sarcopenia comparing Oral testosterone with Placebo (2 arms). Primary endpoint: Lean body mass. Started Aug 2016; status: recruiting.
02
Drugs
testosterone
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on ACTRN12616001166460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001166460.